DockCoV2: a drug database against SARS-CoV-2.
Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2.
H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection.
A comprehensive drug repurposing study for COVID19 treatment: novel putative dihydroorotate dehydrogenase inhibitors show association to serotonin-dopamine receptors.
Brain Disease Network Analysis to Elucidate the Neurological Manifestations of COVID-19.
Systematic elucidation of the pharmacological mechanisms of Rhynchophylline for treating epilepsy via network pharmacology.
The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease.
Gene networks and pathways for plasma lipid traits via multitissue multiomics systems analysis.
Network machine learning maps phytochemically rich "Hyperfoods" to fight COVID-19.
In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors.